Status:
APPROVED_FOR_MARKETING
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
Lead Sponsor:
Abbott
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to assess the safety (by collecting adverse events and serious adverse events) of adalimumab administered every other week to patients with moderately to severly...
Eligibility Criteria
Inclusion
- Patient has completed (i.e. not dropped out of) the DE013 study or fulfills criteria 2-12
- Patients 18 years of age or older
- Female is either not childbearing, defined as post-menopausal for at least 1 year or surgically sterile (bilateral tubal ligation, bilateral oophorectomy or hysterectomy), or if childbearing potential, practicing an acceptable method of birth control
- Female of childbearing potential must have a negative serum pregnancy test prior to first dose of adalimumab
- Diagnosis of active RA defined by \>= 5 swollen joints and one of the following:
- Positive RF
- One or more joint erosions present of x-ray
- HAQ score \> 1
Exclusion
- Patient has failed 2 or more biologics
- Patient who had previous treatment with cyclophosphamide and chlorambucil
- Previous treatment with total lymphoid irradiation or anti-CD4 or CAMPATH 1H monoclonal antibody resulting in presistent CD4 lymphopenia (CD4 lymphocytes +\< 500/mm3)
- History of cancer within the past 10 years unless successfully treated non-metastatic cutaneous squamous cell or basal cell carcinoma and/or localized carcinoma in situ of the cervix
- History of malignant lymphoma or leukemia regardless of treatment
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00649545
Last Update
April 1 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.